diff options
author | clokep <clokep@users.noreply.github.com> | 2021-08-18 12:13:59 +0000 |
---|---|---|
committer | clokep <clokep@users.noreply.github.com> | 2021-08-18 12:13:59 +0000 |
commit | de3a62e58be843b67468e7a31f1117180642fbfa (patch) | |
tree | 3302e1482b7ad984796211a8599752249369d77b /develop/print.html | |
parent | Remove outdated documentation directories (diff) | |
download | synapse-de3a62e58be843b67468e7a31f1117180642fbfa.tar.xz |
deploy: 6e613a10d072c32e72d6b97b2d178bb840769f3e
Diffstat (limited to 'develop/print.html')
-rw-r--r-- | develop/print.html | 6 |
1 files changed, 6 insertions, 0 deletions
diff --git a/develop/print.html b/develop/print.html index f7caf14965..f2cb9d454e 100644 --- a/develop/print.html +++ b/develop/print.html @@ -1579,6 +1579,12 @@ recommend to verify the configuration. It may be necessary to adjust the <code>n environment variable.</p> <p>See <a href="setup/forward_proxy.html">using a forward proxy with Synapse documentation</a> for details.</p> +<h2 id="user-interactive-authentication-fallback-templates-can-now-display-errors"><a class="header" href="#user-interactive-authentication-fallback-templates-can-now-display-errors">User-interactive authentication fallback templates can now display errors</a></h2> +<p>This may affect you if you make use of custom HTML templates for the +<a href="../synapse/res/templates/recaptcha.html">reCAPTCHA</a> or +<a href="../synapse/res/templates/terms.html">terms</a> fallback pages.</p> +<p>The template is now provided an <code>error</code> variable if the authentication +process failed. See the default templates linked above for an example.</p> <h1 id="upgrading-to-v1390"><a class="header" href="#upgrading-to-v1390">Upgrading to v1.39.0</a></h1> <h2 id="deprecation-of-the-current-third-party-rules-module-interface"><a class="header" href="#deprecation-of-the-current-third-party-rules-module-interface">Deprecation of the current third-party rules module interface</a></h2> <p>The current third-party rules module interface is deprecated in favour of the new generic |